Vir Biotechnology, Inc. · NASDAQ:VIR

Vir Biotechnology, Inc. shareholders

As of Sep 30, 2026, 257 institutions reported holding Vir Biotechnology, Inc., 81.8% of its shares. Largest: BlackRock, Vanguard and ARCH Venture Management, LLC. New holders, exits, insiders and big stakes, each with its filing.

HolderShares% of Vir Biotechnology, Inc.ChangeFiled
BlackRock22.4M13.1%+1.77MNov 13, 2026
Vanguard19.6M11.4%+655KNov 16, 2026
ARCH Venture Management, LLC12.7M7.4%no changeNov 16, 2026
Sb Investment Advisers (UK) LTD10.9M6.4%no changeNov 17, 2026
GSK plc8.55M5.0%no changeNov 5, 2026
State Street7.82M4.6%−2.14MNov 12, 2026
Point72 Asset Management, L.P.6.77M4.0%+1.11MNov 16, 2026
Dimensional3.32M1.9%+198KNov 4, 2026
Geode Capital3.02M1.8%−329KNov 6, 2026
Mpm Bioimpact LLC2.81M1.6%newNov 16, 2026

Vir Biotechnology, Inc. insider trades